Granules India jumps on getting USFDA’s nod for Naproxen Sodium, Diphenhydramine Hydrochloride Tablets

25 Sep 2020 Evaluate

Granules India is currently trading at Rs. 375.85, up by 15.25 points or 4.23% from its previous closing of Rs. 360.60 on the BSE.

The scrip opened at Rs. 395.00 and has touched a high and low of Rs. 395.00 and Rs. 370.25 respectively. So far 399493 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 395.00 on 25-Sep-2020 and a 52 week low of Rs. 93.00 on 15-Oct-2019.

Last one week high and low of the scrip stood at Rs. 395.00 and Rs. 331.05 respectively. The current market cap of the company is Rs. 9288.93 crore.

The promoters holding in the company stood at 42.13%, while Institutions and Non-Institutions held 26.16% and 31.71% respectively.

Granules India has received approval from US Food & Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride Tablets, 220 mg/25 mg (OTC), generic equivalent of Aleve PM Tablets, 220 mg/25 mg, of Bayer HealthCare LLC.

Naproxen Sodium and Diphenhydramine Hydrochloride Tablets are used for relief of occasional sleeplessness associated with minor aches and pains and to help you fall asleep and stay asleep. The company now has a total of 31 ANDA approvals from US FDA (29 Final approvals and 2 tentative approvals).

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

614.50 5.70 (0.94%)
09-Jan-2025 13:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1828.85
Dr. Reddys Lab 1380.05
Cipla 1495.20
Lupin 2276.20
Zydus Lifesciences 1020.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.